Jushi Holdings (JUSHF) Shares Outstanding (Diluted Average) (2020 - 2026)
Jushi Holdings (JUSHF) reported Shares Outstanding (Diluted Average) of $198.2 million for Q1 2026, up 1.52% year-over-year from $195.2 million in Q1 2025, and up 1.52% quarter-over-quarter from $195.2 million in Q4 2025.
Jushi Holdings (JUSHF) Shares Outstanding (Diluted Average) (2020 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 7 years of Shares Outstanding (Diluted Average) data on file, last reported at $198.2 million in Q1 2026.
- Shares Outstanding (Diluted Average) for Q1 2026 came in at $198.2 million, up 1.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $198.2 million (up 1.52% YoY), and the FY2025 annual result was $195.2 million, changed 0.02% from the prior year.
- Shares Outstanding (Diluted Average) advanced to $198.2 million in Q1 2026 per JUSHF's latest filing, from $195.2 million in the prior quarter.
- Over five years, Shares Outstanding (Diluted Average) peaked at $208.0 million in Q2 2022 and troughed at $194.1 million in Q1 2023.
- A 5-year average of $197.7 million and a median of $195.2 million in 2025 frame the typical range for Shares Outstanding (Diluted Average).
- The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Diluted Average) rose 7.18% in 2022, then decreased 6.63% in 2023.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $204.2 million in 2022, then fell by 4.63% to $194.8 million in 2023, then rose by 0.2% to $195.2 million in 2024, then grew by 0.02% to $195.2 million in 2025, then climbed by 1.52% to $198.2 million in 2026.
- Business Quant data shows JUSHF's Shares Outstanding (Diluted Average) at $198.2 million in Q1 2026, $195.2 million in Q4 2025, and $195.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 103.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 228.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Jushi Holdings | - | - | 29.88 Mn | 198.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 198.16 Mn |
| Dec 31, 2025 | 195.20 Mn |
| Sep 30, 2025 | 195.20 Mn |
| Jun 30, 2025 | 195.20 Mn |
| Mar 31, 2025 | 195.20 Mn |
| Dec 31, 2024 | 195.16 Mn |
| Sep 30, 2024 | 195.17 Mn |
| Jun 30, 2024 | 195.14 Mn |
| Mar 31, 2024 | 195.13 Mn |
| Dec 31, 2023 | 194.77 Mn |
| Sep 30, 2023 | 195.13 Mn |
| Jun 30, 2023 | 194.41 Mn |
| Mar 31, 2023 | 194.05 Mn |
| Dec 31, 2022 | 204.24 Mn |
| Sep 30, 2022 | 203.17 Mn |
| Jun 30, 2022 | 208.04 Mn |
| Mar 31, 2022 | 207.84 Mn |
| Dec 31, 2021 | 201.61 Mn |
| Sep 30, 2021 | 199.28 Mn |
| Jun 30, 2021 | 194.10 Mn |